|
Contact: Market News First |
RegeneRx CEO to Air on Live MN1 Interview RegeneRx CEO to Air on Live MN1 Interview August 6, 2007 — Bethesda, Md RegeneRx Biopharmaceuticals, Inc. (AMEX: RGN), www.regenerx.com announced today that J.J. Finklestein, CEO of RegeneRx, will be appearing on Market News First www.mn1.com at 10:00 AM CDT on August 6, 2007. Finklestein will be talking with Rich Hancock and Bob Leonard about their revolutionary tissue and organ repairing biopharmaceuticals. To learn more about RegeneRx and how it is changing the marketplace, log onto www.mn1.com on August 6, 2007. About RegeneRx Biopharmaceuticals, Inc. RegeneRx utilizes an outsourcing business model in order to effectively control costs while focusing on clinical development of our drug candidates. This model is used for research and development, manufacturing, drug formulation and clinical trials, as well as for other functions critical to its mission and enhances RegeneRx's ability to allocate resources rapidly to different projects without having to invest in infrastructure. www.regenerx.com About MN1.com Through daily, live interviews, Market News First brings you up to date on all the well-respected and established companies and informs investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask. This service provides them with insight into the companies' present condition and future plans. SOURCE: RegeneRx Biopharmaceuticals, Inc. |
